Sep 26, 2023 01:43PM
Sep 5, 2023 08:30AM
Oct 3, 2022 06:43AM
Sep 7, 2022 08:00AM
Sep 3, 2020 08:00AM
May 22, 2020 10:14AM
Dec 17, 2019 06:56AM Intercept Pharmaceuticals (ICPT) Outlines It's NASH Plans at Analyst Day - Baird
Nov 25, 2019 09:43AM
Nov 25, 2019 09:30AM
Nov 5, 2019 01:03PM
Sep 30, 2019 07:29AM
Aug 23, 2019 08:00AM
Jun 6, 2019 02:31PM
May 10, 2019 08:31AM Intercept Pharma (ICPT) Prices Offerings of Common Stock and Convertible Senior Notes due 2026
May 10, 2019 08:30AM
Feb 19, 2019 09:51AM
Feb 12, 2019 07:45AM
Aug 29, 2018 07:05AM
May 31, 2018 03:17PM
Feb 1, 2018 10:13AM
Jan 25, 2018 05:53AM Intercept Pharmaceuticals (ICPT) PT Lowered to $253 at Baird on Ocaliva Label Uncertainty
Oct 30, 2017 06:33AM
Sep 25, 2017 01:25PM
Sep 25, 2017 10:16AM
Sep 21, 2017 03:35PM
Sep 12, 2017 11:09AM
Sep 1, 2017 04:05PM
Feb 10, 2017 12:17PM Intercept (ICPT) NASH Trial Updates Offers 'Positives and Negatives' - Baird
Nov 3, 2016 01:01PM
Sep 20, 2016 10:27AM
Sep 2, 2016 07:30AM
Aug 5, 2016 10:45AM
Jun 15, 2016 06:10AM
Jun 8, 2016 06:08PM
May 31, 2016 11:55AM Intercept (ICPT) Most Lucrative Opportunity Remains in NASH - Baird
Apr 8, 2016 07:02AM
Apr 7, 2016 07:10AM
Apr 5, 2016 10:32AM
Dec 18, 2015 07:41AM
Dec 4, 2015 11:28AM
Nov 9, 2015 02:09PM
Oct 28, 2015 02:35PM Intercept's (ICPT) OCA Phase 2 in Japan Not 'Clear Miss'; Baird Maintains at 'Outperform'
Sep 15, 2015 05:45PM
Sep 8, 2015 07:05AM
Sep 8, 2015 07:05AM
Jun 30, 2015 06:44AM
Mar 26, 2015 04:40PM
Mar 20, 2015 10:12AM
Mar 18, 2015 06:18AM Intercept Pharmaceuticals (ICPT) PT Raised at Baird on Increased Confidence in Accelerated Path to Approval
Jan 29, 2015 06:11PM

27,186 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All